Eli Lilly to buy gene therapy biotech company in a deal valued at $1 billion
Eli Lilly and Co. announced Tuesday it will buy biotechnology company Prevail Therapeutics Inc. in a deal valued at about $1 billion.
Eli Lilly and Co. announced Tuesday it will buy biotechnology company Prevail Therapeutics Inc. in a deal valued at about $1 billion.